The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
The Inhibition of Arginase by N ω-Hydroxy-l-Arginine Controls the Growth of Leishmania Inside Macrophages
Open accessAbstract
Polyamine synthesis from l-ornithine is essential for Leishmania growth. We have investigated the dependence of Leishmania infection on arginase, which generates l-ornithine, in macrophages from BALB/c, C57BL/6, and nitric oxide synthase II (NOS II)-deficient mouse strains. We have found that Nω-hydroxy-l-arginine (LOHA), a physiological inhibitor of arginase, controls cellular infection and also specifically inhibits arginase activity from Leishmania major and Leishmania infantum parasites. The effect was proportional to the course of infection, concentration dependent up to 100 μM, and achieved without an increase in nitrite levels of culture supernatants. Moreover, when the l-arginine metabolism of macrophages is diverted towards ornithine generation by interleukin 4–induced arginase I, parasite growth is promoted. This effect can be reversed by LOHA. Inhibition of NOS II by NG-methyl-l-arginine (LNMMA) restores the killing obtained in the presence of interferon (IFN)-γ plus lipolysaccharide (LPS), whereas the nitric oxide scavenger 2-(4-carboxyphenyl)-4,4,5,5,-tetramethylimidazoline-3-oxide-1-oxyl (carboxy-PTIO) was without effect. However, exogenous l-ornithine almost completely inhibits parasite killing when added in the presence of LOHA to macrophages from NOS II–deficient mice or to BALB/c-infected cells activated with IFN-γ plus LPS. These results suggest that LOHA is an effector molecule involved in the control of Leishmania infection. In addition, macrophage arginase I induction by T helper cell type 2 cytokines could be a mechanism used by parasites to spread inside the host.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287 · cited 10×
“Inhibition of NOS II by N G -methyll -arginine (LNMMA) restores the killing obtained in the presence of interferon (IFN)g plus lipolysaccharide (LPS), whereas the nitric oxide scavenger 2-(4-carboxyphenyl)-4,4,5,5,-tetramethylimidazoline-3-oxide-1-oxyl (carboxy-PTIO) was without effect.”
ResultInfluentialAn improved colorimetric assay for interleukin 2
Tada, H., Shiho, O., Kuroshima, K.-I., Koyama, M., & Tsukamoto, K. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90183-3 · Cited by 869
The role of nitric oxide in innate immunity: NO in innate immunity
Bogdan, C., Röllinghoff, M., & Diefenbach, A. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917307.x · Cited by 662
Munder, M., Eichmann, K., & Modolell, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5347 · Cited by 647
N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine.
Stuehr, D. J., Kwon, N. S., Nathan, C. F., Griffith, O. W., Feldman, P. L., & Wiseman, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38112-2 · Cited by 575
Modolell, M., Corraliza, I. M., Link, F., Soler, G., & Eichmann, K. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250436 · Cited by 554
Self-citationMurray, H. W., & Nathan, C. F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.741 · Cited by 418
Corraliza, I. M., Soler, G., Eichmann, K., & Modolell, M. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1094 · Cited by 365
Self-citationProduction of nitric oxide and superoxide by activated macrophages and killing of Leishmania major
Assreuy, J., Cunha, F. Q., Epperlein, M., Noronha‐Dutra, A., O'Donnell, C. A., Liew, F. Y., & Moncada, S. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240328 · Cited by 270
Singh, R., Pervin, S., Karimi, A., Cederbaum, S. D., & Chaudhuri, G. (2000) · PubMed · Cited by 216
Cited by
Nitric oxide and the immune response
Bogdan, C. (2001) · Nature Immunology · doi:10.1038/ni1001-907 · Cited by 3,447
The metabolic signature of macrophage responses
Viola, A., Munari, F., Sánchez-Rodríguez, R., Scolaro, T., & Castegna, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01462 · Cited by 2,021
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Arginase: an emerging key player in the mammalian immune system
Munder, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00291.x · Cited by 694
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
Rodriguez, P. C., Hernandez, C. P., Quiceno, D., Dubinett, S. M., Zabaleta, J., Ochoa, J. B., Gilbert, J., & Ochoa, A. C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050715 · Cited by 609
The role of nitric oxide in inflammatory reactions: Nitric oxide: control of immune response
Tripathi, P., Tripathi, P., Kashyap, L., & Singh, V. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00329.x · Cited by 511
RetractedGobert, A. P., McGee, D. J., Akhtar, M., Mendz, G. L., Newton, J. C., Cheng, Y., Mobley, H. L. T., & Wilson, K. T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241443798 · Cited by 380
Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity
Munder, M. (2005) · Blood · doi:10.1182/blood-2004-07-2521 · Cited by 335
Alternatively activated macrophages during parasite infections
Noël, W. (2004) · Trends in Parasitology · doi:10.1016/j.pt.2004.01.004 · Cited by 301
Kropf, P., Fuentes, J. M., Fähnrich, E., Arpa, L., Herath, S., Weber, V., Soler, G., Celada, A., Modolell, M., & Müller, I. (2005) · The FASEB Journal · doi:10.1096/fj.04-3416fje · Cited by 297
Immunopathogenesis of infection with the visceralizing Leishmania species
Wilson, M. E., Jeronimo, S. M. B., & Pearson, R. D. (2005) · Microbial Pathogenesis · doi:10.1016/j.micpath.2004.11.002 · Cited by 281
Cysteine peptidases as virulence factors of Leishmania
Mottram, J. C., Coombs, G. H., & Alexander, J. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.06.010 · Cited by 263
Mechanisms of Immune Evasion in Leishmaniasis
Gupta, G., Oghumu, S., & Satoskar, A. R. (2013) · Advances in Applied Microbiology · doi:10.1016/b978-0-12-407679-2.00005-3 · Cited by 259
Das, P., Lahiri, A., Lahiri, A., & Chakravortty, D. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000899 · Cited by 247
Nitric Oxide in Macrophage Immunometabolism: Hiding in Plain Sight
Palmieri, E. M., McGinity, C., Wink, D. A., & McVicar, D. W. (2020) · Metabolites · doi:10.3390/metabo10110429 · Cited by 237
“Moreover, the NOS intermediate NOHA, supporting effective NO production by suppressing arginase activity freeing cellular arginine for NO production [139], has been shown to be critical in controlling parasites such as Leishmania [140].”
BackgroundLiver X receptors as regulators of macrophage inflammatory and metabolic pathways
A-González, N., & Castrillo, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.015 · Cited by 139
Metadata
- Authors
- Iniesta, V., Gómez-Nieto, L. C., & Corraliza, I.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2001-03-19
- Volume
- 193
- Issue
- 6
- Pages
- 777-784
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2108173186
- Cited by
- 267
- References
- 25
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.